[Ip-health] UN GA: A/74/L.56 - E - A/74/L.56. International cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19

James Love james.love at keionline.org
Tue Apr 21 11:38:42 PDT 2020

This the General Assembly Resolution on COVID-19.

Does not mention patents or other IP issues.


United Nations A/74/L.56
General Assembly Distr.: Limited
8 April 2020
Original: English
20-05435 (E) 130420
Seventy-fourth session
Agenda item 123

Strengthening of the United Nations system

Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Azerbaijan,
Barbados, Belize, Bosnia and Herzegovina, Canada, Central African Republic,
Costa Rica, Côte d’Ivoire, Djibouti, Dominican Republic, Ecuador, El
Salvador, Equatorial Guinea, Fiji, Gambia, Georgia, Ghana, Grenada,
Guatemala, Guyana, Honduras, Iraq, Jamaica, Jordan, Kazakhstan, Kenya,
Lebanon, Lesotho, Libya, Liechtenstein, Madagascar, Malawi, Maldives,
Mauritius, Mexico, Micronesia (Federated States of), Morocco, Namibia,
Nepal, Niger, Nigeria, Norway, Palau, Panama, Papua New Guinea, Paraguay,
Peru, Republic of Korea, Rwanda, Saint Lucia, Saint Vincent and the
Grenadines, Samoa, Senegal, Seychelles, Singapore, Sri Lanka, Sudan,
Suriname, Tajikistan, Thailand, Timor-Leste, Trinidad and Tobago, Turkey,
Turkmenistan, Ukraine, United Republic of Tanzania, Uruguay, Vanuatu, Viet
Nam and Zimbabwe:

International cooperation to ensure global access to medicines, vaccines
and medical equipment to face COVID-19

The General Assembly,

Recalling its resolutions 74/270 of 2 April 2020 and 74/2 of 10 October
2019, Noting with concern the threat to human health, safety and well-being
caused by the coronavirus disease 2019 (COVID-19) pandemic, which has
spread all around the globe, as well as the unprecedented and multifaceted
effects of the pandemic, including the severe disruption to societies,
economies, global trade and travel and the devastating impact on the
livelihoods of people,

Recognizing the competence, generosity and personal sacrifice of
health-care professionals and services in the exercise of their duties to
contain the spread of the pandemic,

Reaffirming the right of every human being, without distinction of any
kind, to the enjoyment of the highest attainable standard of physical and
mental health, Recognizing that the poor and the most vulnerable people are
the most affected and that the impact of the pandemic will have
repercussions on development gains, hampering progress in the achievement
of the Sustainable Development Goals, including target 3.8,1

Underscoring that equitable access to health products is a global priority
and that the availability, accessibility, acceptability and affordability
of health products of assured quality are fundamental to tackling the
pandemic, Recognizing the importance of international cooperation and
effective multilateralism in helping to ensure that all States have in
place effective national protective measures, access to and flow of vital
medical supplies, medicines and vaccines, in order to minimize negative
effects in all affected States and to avoid relapses of the pandemic,

Recognizing also that the COVID-19 global pandemic requires a global
response based on unity, solidarity and multilateral cooperation,

1. Reaffirms the fundamental role of the United Nations system in
coordinating the global response to control and contain the spread of the
coronavirus disease (COVID-19) and in supporting Member States, and in this
regard acknowledges the crucial leading role played by the World Health

2. Requests the Secretary-General, in close collaboration with the World
Health Organization and other relevant agencies of the United Nations
system, including the international financial institutions, to identify and
recommend options, including approaches to rapidly scaling manufacturing
and strengthening supply chains that promote and ensure fair, transparent,
equitable, efficient and timely access to and distribution of preventive
tools, laboratory testing, reagents and supporting materials, essential
medical supplies, new diagnostics, drugs and future COVID-19 vaccines, with
a view to making them available to all those in need, in particular in
developing countries;

3. Encourages Member States to work in partnership with all relevant
stakeholders to increase research and development funding for vaccines and
medicines, leverage digital technologies, and strengthen scientific
international cooperation necessary to combat COVID-19 and to bolster
coordination, including with the private sector, towards rapid development,
manufacturing and distribution of diagnostics, antiviral medicines,
personal protective equipment and vaccines, adhering to the objectives of
efficacy, safety, equity, accessibility, and affordability;

4. Calls upon Member States and other relevant stakeholders to immediately
take steps to prevent, within their respective legal frameworks,
speculation and undue stockpiling that may hinder access to safe, effective
and affordable essential medicines, vaccines, personal protective equipment
and medical equipment as may be required to effectively address COVID-19;

5. Requests the Secretary-General, in close collaboration with the World
Health Organization, to take the necessary steps to effectively coordinate
and follow up on the efforts of the United Nations system to promote and
ensure global access to medicines, vaccines and medical equipment needed to
face COVID-19, and, in this regard, to consider establishing, within
existing resources, an inter-agency task force, and to brief the General
Assembly on such efforts, as appropriate.

1 See resolution 70/1.

More information about the Ip-health mailing list